Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Diabetes Investig ; 13(7): 1277-1285, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-35243802

RESUMO

AIMS/INTRODUCTION: Diabetes mellitus is reported as a risk factor for increased coronavirus disease 2019 (COVID-19) severity and mortality, but there have been few reports from Japan. Associations between diabetes mellitus and COVID-19 severity and mortality were investigated in a single Japanese hospital. MATERIALS AND METHODS: Patients aged ≥20 years admitted to Osaka City General Hospital for COVID-19 treatment between April 2020 and March 2021 were included in this retrospective, observational study. Multivariable logistic regression analysis was carried out to examine whether diabetes mellitus contributes to COVID-19-related death and severity. RESULTS: Of the 262 patients included, 108 (41.2%) required invasive ventilation, and 34 (13.0%) died in hospital. The diabetes group (n = 92) was significantly older, more obese, had longer hospital stays, more severe illness and higher mortality than the non-diabetes group (n = 170). On multivariable logistic regression analysis, age (odds ratio [OR] 1.054, 95% confidence interval [CI] 1.023-1.086), body mass index (OR 1.111, 95% CI 1.028-1.201), history of diabetes mellitus (OR 2.429, 95% CI 1.152-5.123), neutrophil count (OR 1.222, 95% CI 1.077-1.385), C-reactive protein (OR 1.096, 95% CI 1.030-1.166) and Krebs von den Lungen-6 (OR 1.002, 95% CI 1.000-1.003) were predictors for COVID-19 severity (R2 = 0.468). Meanwhile, age (OR 1.104, 95% CI 1.037-1.175) and Krebs von den Lungen-6 (OR 1.003, 95% CI 1.001-1.005) were predictors for COVID-19-related death (R2 = 0.475). CONCLUSIONS: Diabetes mellitus was a definite risk factor for COVID-19 severity in a single Japanese hospital treating moderately-to-severely ill patients.


Assuntos
Tratamento Farmacológico da COVID-19 , COVID-19 , Diabetes Mellitus , Fatores Etários , COVID-19/complicações , COVID-19/epidemiologia , Diabetes Mellitus/epidemiologia , Humanos , Japão/epidemiologia , Estudos Retrospectivos , Fatores de Risco , SARS-CoV-2 , Índice de Gravidade de Doença
3.
Diabetes Metab Syndr ; 12(2): 203-206, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29208515

RESUMO

An 83-year-old man developed hypoglycemia after undergoing total gastrectomy for gastric cancer in 200X-4. The patient was admitted to our hospital in May 200X and placed on continuous glucose monitoring (CGM). Glycemic excursions were examined while on 3-meal/day (1700kcal) and 6-meal/day (1800kcal) diets. Oxyhyperglycemia followed about 2h later by a sudden drop in glucose levels was seen with both regimens. These findings were consistent with late dumping syndrome. CGM was continued, oral miglitol at 150mg/day or sitagliptin at 50mg/day was started, and glycemic excursions were compared. Results were similar for both drugs, with reductions in postprandial glucose elevations. Meal tolerance testing 3 months after oral sitagliptin, compared to before starting treatment, showed reductions in both early postprandial hyperglycemia and insulin hypersecretion. These findings suggest that DPP-4 inhibitors such as sitagliptin may be effective for treating post-gastrectomy late dumping syndrome.


Assuntos
Inibidores da Dipeptidil Peptidase IV/uso terapêutico , Síndrome de Esvaziamento Rápido/tratamento farmacológico , Gastrectomia/efeitos adversos , Complicações Pós-Operatórias/tratamento farmacológico , Fosfato de Sitagliptina/uso terapêutico , Idoso de 80 Anos ou mais , Síndrome de Esvaziamento Rápido/diagnóstico , Síndrome de Esvaziamento Rápido/etiologia , Humanos , Masculino , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/etiologia , Resultado do Tratamento
4.
Intern Med ; 53(19): 2211-4, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25274232

RESUMO

We encountered a case of epithelioid inflammatory myofibroblastic sarcoma (EIMS) originating from an abdominal organ that rapidly regrew twice. The patient underwent two surgeries. Large tumors grew within three months after the second surgery. The patient subsequently received chemotherapy with an anaplastic lymphoma kinase (ALK) inhibitor. Although EIMS has a poor prognosis, the patient continues to be alive with disease 14 months after surgical treatment and the administration of the ALK inhibitor.


Assuntos
Inibidores Enzimáticos/uso terapêutico , Hipopituitarismo/complicações , Neoplasias Intestinais/terapia , Laparotomia/métodos , Receptores Proteína Tirosina Quinases/antagonistas & inibidores , Sarcoma/terapia , Quinase do Linfoma Anaplásico , Colonoscopia , Terapia Combinada , Seguimentos , Humanos , Hipopituitarismo/diagnóstico , Neoplasias Intestinais/complicações , Neoplasias Intestinais/diagnóstico , Intestino Delgado , Masculino , Receptores Proteína Tirosina Quinases/metabolismo , Sarcoma/complicações , Sarcoma/diagnóstico , Tomografia Computadorizada por Raios X , Adulto Jovem
5.
World J Gastroenterol ; 16(26): 3339-42, 2010 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-20614493

RESUMO

We report a case of 71-year-old man who developed a hypersensitivity syndrome associated with terbinafine. He was placed on terbinafine (250 mg/d) for the treatment of tinea pedis due to diabetes mellitus. Following the treatment with terbinafine, he developed drug-induced hypersensitivity syndrome (DIHS). Systemic corticosteroid led to transient improvement of his clinical manifestations. Three months after disease onset, he presented with panperitonitis due to ileal perforation, and underwent an emergency operation. The affected ileum was resected and ileostomy was performed in the terminal ileum. Cytomegalovirus (CMV)-specific IgG antibodies were significantly increased, high-titer CMV antigenemia was detected, and pathological examination of the resected ileum confirmed CMV infection. Based on these observations, we strongly recommend that physicians monitor reactivation of the family of herpesvirus other than herpesvirus 6, to manage DIHS properly.


Assuntos
Infecções por Citomegalovirus/complicações , Hipersensibilidade a Drogas/complicações , Doenças do Íleo/etiologia , Perfuração Intestinal/etiologia , Naftalenos/efeitos adversos , Corticosteroides/efeitos adversos , Idoso , Antifúngicos/efeitos adversos , Hipersensibilidade a Drogas/tratamento farmacológico , Infecções por Vírus Epstein-Barr/etiologia , Herpesvirus Humano 6 , Humanos , Masculino , Recidiva , Infecções por Roseolovirus/etiologia , Terbinafina , Tinha dos Pés/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA